Globe Life shares edge higher, chart eyes the 188.92 resistance
Published on 06/26/2026 at 10:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-26, 08:06.
Globe Life (US37959E1029) trades on the NYSE in New York and closed at 176.60 dollars on June 25. TradingKey puts the next resistance at 188.92 dollars and the support at 156.11 dollars, while MarketBeat showed the stock at 176.80 dollars after the close. TradingKey technical data
What the chart shows
The technical picture is still range bound. TradingKey reports a momentum score of 9.45 and six buy signals from moving averages versus zero sell signals. MarketBeat quote page
That keeps the NYSE listing in focus for short-term traders. The same page shows Globe Life at a 12.04 price-to-earnings ratio and a 13.75 billion dollar market cap at the last close. TradingKey valuation snapshot
Analyst tone stays firm
Zacks kept Globe Life at a Rank #2, or Buy, in a June 2026 note on the insurer. The same article pointed to 3.88 percent weekly share gains and a 3.65 percent rise for the insurance and accident and health peer group. Zacks update
Background and price data on Globe Life
The NYSE-listed insurer combines life insurance and supplemental health products with a chart that is still trading below the June resistance band.
The business behind it
Globe Life sells life insurance and supplemental health coverage through its insurance units. That mix is the core of the Dallas-based company’s earnings model and the reason the stock often trades with a steady insurance-sector profile.
Where the shares trade
The Globe Life shares (US37959E1029) traded on June 25, 2026 at 176.60 dollars on the NYSE.
Key data on the Globe Life shares
- Company: Globe Life Inc.
- ISIN: US37959E1029
- Ticker: GL
- Trading venue: NYSE
- Price (as of 2026-06-25, 16:00 ET): 176.60 USD
- Market cap: 13.75 billion USD
- Sector / industry: Financials / Insurance
- Next earnings date: not officially scheduled
Disclaimer: This article is for information only and does not constitute investment advice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
